Acta 184 , 42954303 (2017)
Additionally, while proponents argue that small molecules are cheaper to manufacture than biologics, whether those savings will be passed on to the patient or simply absorbed into the profit margins remains to be seen, with projected self-pay costs in some cases exceeding $1,000 per month
Lots of GLP-1 users can currently afford their prescriptions thanks to cheaper, compounded versions being available while branded drugs are in short supply
Join our community Expert content, healing insights and free webinar invitations
Tirzepatide, which produces the greatest average weight loss, was most frequently linked to telogen effluvium specifically
Your prescriber can help determine which compound aligns with your clinical needs and budget